NCT03907280View on ClinicalTrials.gov

A Study in Healthy Men That Tests if Taking BI 1265162 by Mouth, Intravenously, or Inhaled Influences the Amount of BI 1265162 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

December 6, 2019

Study Completion Date

December 6, 2019

Conditions
Healthy
Interventions
DRUG

BI 1265162 (T1)

oral solution

DRUG

BI 1265162 (T2)

Solution for inhalation

DRUG

BI 1265162 (R)

concentrate for i.v. solution

DRUG

BI 1265162 (T3)

Solution for inhalation

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03907280 - A Study in Healthy Men That Tests if Taking BI 1265162 by Mouth, Intravenously, or Inhaled Influences the Amount of BI 1265162 in the Blood | Biotech Hunter | Biotech Hunter